DEINOVE granted six new US patents

In France, DEINOVE announced that it has been granted six new patents in the United States:

• • “Process for chromosomal engineering using a novel DNA repair system”, Deinove’s founding patent, already registered in Europe. It describes the mechanism behind the biodiversity and resistance of Deinococcus bacteria, a major discovery made by Prof. Miroslav Radman’s team and which led to the launch of Deinove.
• • “Methods for isolating bacteria” protects a method for selecting and identifying bacteria that has enabled the company to build a strain library with over 6,000 bacterial strains, all resistant to UV radiation.
• • Four other patents grant Deinove with a clear leading edge over the exploitation of Deinococcus bacteria in view of producing biofuels as part of the Deinol program:
  • o “Use of bacteria for the production of bio-energy”, already issued, notably in Europe, Eurasia and Australia, protects the production of biofuel from lignocellulosic biomass by using Deinococcus bacteria.
  • o “Compositions and methods for degrading lignocellulosic biomass”, already issued, notably in China, extends the previous patent to other bacteria related to Deinococci and which are present in the Deinove strain library.
  • o “Recombinant bacteria and the use of thereof for producing ethanol” protects Deinococci that have undergone genomic modifications in view of bioethanol production.
  • o “Laccases and uses of thereof” protects enzymes involved in degrading lignin, namely Deinococcus laccases, as well as their use in degrading or modifying biomass.

These patents were issued following the “High-performance metabolic bacteria” patent issued at the end of 2014 and dealing with the method of biofuel production from cellulosic or hemicellulosic raw materials using an integrated process for degradation and fermentation based on Deinococcus bacteria.